Salipro presenting at PEGS Boston
This week Salipro Biotech will be at PEGS Boston (May 2-6)! Our CSO Robin Löving will be presenting the latest developments on the oncology drug target CXCR4 with the Salipro® platform.
Please reach out to Robin if you’re interested in discussing drug development against challenging targets.
